| 000 | 01631 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514184808.0 | ||
| 264 | 0 | _c20040723 | |
| 008 | 200407s 0 0 spa d | ||
| 022 | _a0210-0010 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCasadevall Codina, T | |
| 245 | 0 | 0 |
_a[Paraproteinemic neuropathies: foundations for a specific therapy related to patients' quality of life]. _h[electronic resource] |
| 260 |
_bRevista de neurologia _c |
||
| 300 |
_a631-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDemyelinating Diseases _xetiology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGait Disorders, Neurologic _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xcomplications |
| 650 | 0 | 4 |
_aParaproteinemias _xcomplications |
| 650 | 0 | 4 |
_aParesthesia _xetiology |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xetiology |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aPérez Lázaro, C | |
| 700 | 1 | _aSantos, S | |
| 700 | 1 | _aFabre Pi, O | |
| 700 | 1 | _aGarcés Redondo, M | |
| 700 | 1 | _aLarrodé Pellicer, P | |
| 773 | 0 |
_tRevista de neurologia _gvol. 38 _gno. 7 _gp. 631-6 |
|
| 999 |
_c14809956 _d14809956 |
||